Nano Science & Nano Technology: An Indian Journal

Open Access Open Access  Restricted Access Subscription Access

The Release Property of Amoxicillin Nanoparticle and their Antibacterial Activity


Affiliations
1 Nanomedicine-Laboratory of Immunology and Biomedical Research, School of Medicine, Deakin University, 75 Pigdons Rd Geelong, Australia
2 Biotechnology Department, College of Science, Al Nahrain University, Baghdad, Iraq
3 College of Pharmacy, Al Mustansyria University, Baghdad, Iraq
 

Early efforts have been made in an attempt to reduce the adverse side effect of multiple drug resistance organisms, and new classes of antimicrobial nanoparticles (NPs) and nanosized carriers for antibiotics delivery were developed. PURPOSE: This study was focused on the assessment of the physiochemical characterization, In vitro drug release, biofilm formation and antimicrobial properties of amoxicillin encapsulated within the Poly (ε-caprolactone) (PCL) nanoparticles. Methods: amoxicillin (AMX) nanoparticles were prepared using the emulsion solvent evaporation method with different concentrations of polycaprolactone (PCL) and Poly Vinyl Alcohol (PVA). These nanoparticles were subsequently characterized and evaluated for their antibacterial activity and biofilm inhibition activity using mean and standard error for Data analysis. Results: It was found that increased PCL concentration resulted in an increase in entrapment efficiency (EE%) to 83.3%. Meanwhile, an increase in the PVA concentration led to a decrease in the EE% and an increase in nanoparticle size. Enhancements in the percentage of practical yield to 80.2% as the polymer concentration rose. Fourier transform infrared spectra data for the MNPs, CS-coated AMX, and AMX-PCL-NPs nanoparticles were compared, which confirmed the PCL coating on the AMX and the AMX-PCL-NPs loaded nanoparticles. In addition, the antimicrobial activity of the nanoparticles e was determined using agar diffusion and growth inhibition assays against both gram-positive Staphylococcus aureus, gram-negative Pseudomonas aeruginosa and Proteus mirabilis bacteria. Furthermore, 10 μg/ml was the minimum inhibitory concentration of the AMX-PCL-NPs nanoparticle which inhibited biofilm formation in Staphylococcus aureus bacteria. Conclusion: Thus, this study presents a novel ß-lactam antibacterial-nanocarrier system that can reduce and inhibit bacterial growth showing it to be a promising tool for numerous medical applications.

Keywords

Poly (ε-caprolactone), Poly Vinyl Alcohol, Amoxicillin Nanoparticle, Antimicrobial Activity, Biofilm.
User
Notifications
Font Size


  • The Release Property of Amoxicillin Nanoparticle and their Antibacterial Activity

Abstract Views: 296  |  PDF Views: 0

Authors

Maysaa Ch. AL-Mohammedawi
Nanomedicine-Laboratory of Immunology and Biomedical Research, School of Medicine, Deakin University, 75 Pigdons Rd Geelong, Australia
Rana A. Mohsien
Biotechnology Department, College of Science, Al Nahrain University, Baghdad, Iraq
Mokhtar J. Kadhim
Biotechnology Department, College of Science, Al Nahrain University, Baghdad, Iraq
Enas S. Bahjat
Biotechnology Department, College of Science, Al Nahrain University, Baghdad, Iraq
Duna Q. Al Azawi
Biotechnology Department, College of Science, Al Nahrain University, Baghdad, Iraq
Samra A. Qaraghuli
College of Pharmacy, Al Mustansyria University, Baghdad, Iraq

Abstract


Early efforts have been made in an attempt to reduce the adverse side effect of multiple drug resistance organisms, and new classes of antimicrobial nanoparticles (NPs) and nanosized carriers for antibiotics delivery were developed. PURPOSE: This study was focused on the assessment of the physiochemical characterization, In vitro drug release, biofilm formation and antimicrobial properties of amoxicillin encapsulated within the Poly (ε-caprolactone) (PCL) nanoparticles. Methods: amoxicillin (AMX) nanoparticles were prepared using the emulsion solvent evaporation method with different concentrations of polycaprolactone (PCL) and Poly Vinyl Alcohol (PVA). These nanoparticles were subsequently characterized and evaluated for their antibacterial activity and biofilm inhibition activity using mean and standard error for Data analysis. Results: It was found that increased PCL concentration resulted in an increase in entrapment efficiency (EE%) to 83.3%. Meanwhile, an increase in the PVA concentration led to a decrease in the EE% and an increase in nanoparticle size. Enhancements in the percentage of practical yield to 80.2% as the polymer concentration rose. Fourier transform infrared spectra data for the MNPs, CS-coated AMX, and AMX-PCL-NPs nanoparticles were compared, which confirmed the PCL coating on the AMX and the AMX-PCL-NPs loaded nanoparticles. In addition, the antimicrobial activity of the nanoparticles e was determined using agar diffusion and growth inhibition assays against both gram-positive Staphylococcus aureus, gram-negative Pseudomonas aeruginosa and Proteus mirabilis bacteria. Furthermore, 10 μg/ml was the minimum inhibitory concentration of the AMX-PCL-NPs nanoparticle which inhibited biofilm formation in Staphylococcus aureus bacteria. Conclusion: Thus, this study presents a novel ß-lactam antibacterial-nanocarrier system that can reduce and inhibit bacterial growth showing it to be a promising tool for numerous medical applications.

Keywords


Poly (ε-caprolactone), Poly Vinyl Alcohol, Amoxicillin Nanoparticle, Antimicrobial Activity, Biofilm.

References